Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa‐2a by intramuscular injection
暂无分享,去创建一个
J. Gutterman | J. Groopman | L. Itri | M. Campion | A. Palleroni | P. Trown | R. Dennin
[1] M. Rainisio,et al. The detection of antibodies to recombinant interferon alfa-2a in human serum. , 1987, Journal of biological standardization.
[2] L. Itri,et al. Safety and tolerance of recombinant interferon alfa‐2a (roferon®‐A) in Cancer Patients , 1986, Cancer.
[3] R. Spiegel,et al. Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A). , 1986, The American journal of medicine.
[4] J. Quesada,et al. Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Quesada,et al. Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] D. K. Kelsey,et al. A radioimmunologic technique to screen for antibodies to α-2 interferon , 1984 .
[7] D. Longo,et al. Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon. , 1984, The New England journal of medicine.
[8] D. Longo,et al. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. , 1984, Annals of internal medicine.
[9] T. Merigan,et al. Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma. , 1984, The American journal of medicine.
[10] J. Quesada,et al. Clinical study of recombinant DNA-produced leukocyte interferon (clone A) in a intermittent schedule in cancer patients. , 1983, Journal of the National Cancer Institute.
[11] F. Real,et al. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. , 1983, The New England journal of medicine.
[12] J. Quesada,et al. Renal cell carcinoma: antitumor effects of leukocyte interferon. , 1983, Cancer research.
[13] J. Quesada,et al. ANTIBODIES TO HUMAN LEUCOCYTE INTERFERONS IN CANCER PATIENTS , 1983, The Lancet.
[14] T. Merigan,et al. Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. , 1982, Annals of internal medicine.
[15] D. Niethammer,et al. Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon , 1981, Nature.